Indoco Remedies Gains 1.53%: Key Intraday Surge and Mixed Technical Signals Shape Week
2026-11-21 17:01:09Key Events This Week 16 Nov: Technical momentum shifts amid mixed signals 18 Nov: Intraday high with 11.87% surge 20 Nov: Week closes at Rs.231.80 (+1.53%) Week OpenRs.226.90 Week CloseRs.231.80+1.53% Week High<div...
Read More
Indoco Remedies Ltd Surges 11.87% to Day's High of Rs 250.3 — Outperforms Sector by 11.37 Percentage Points
2026-11-18 09:31:37The Sensex declined 0.33% on 18 Nov 2026, while Indoco Remedies Ltd surged 11.87%, marking a remarkable 11.37-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This sharp single-session gain rewrites the short-term narrative for the stock, which had been under pressure in recent weeks.
Read More
Indoco Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-11-16 08:02:17Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a modest day change of 0.02% and a current price of ₹228.30, the stock’s technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes.
Read More
Indoco Remedies Ltd is Rated Sell
2026-11-11 10:10:52Indoco Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreIndoco Remedies Declines 8.34%: Mixed Technical Signals and Margin Pressures Shape the Week
2026-10-31 17:00:06Key Events This Week 26 Oct: Stock opens at ₹227.30 but drops 3.30% to ₹219.80 amid technical momentum shift 27 Oct: Slight recovery to ₹220.65 despite broader market gains 28 Oct: Quarterly results reveal flat performance with margin pressures 29 Oct: Technical momentum shifts again as stock falls to ₹214.05 30 Oct: Week closes at ₹208.35, down 0.67% on the day Week Open<div class...
Read More
Indoco Remedies Ltd is Rated Sell
2026-10-31 10:10:24Indoco Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 October 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Indoco Remedies Ltd Faces Technical Momentum Shift Amid Mixed Market Signals
2026-10-29 08:01:39Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. The stock’s recent downgrade from a Strong Sell to a Sell rating by MarketsMojo, alongside a 2.99% decline in daily price, underscores the evolving market sentiment and technical landscape investors must carefully analyse.
Read More
Indoco Remedies Ltd Reports Flat Quarterly Performance Amid Margin Pressures
2026-10-28 08:00:12Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended September 2026, signalling a pause in its recent downward trend. Despite achieving its highest quarterly net sales to date, the company faces margin pressures due to rising interest costs, prompting a cautious outlook from analysts.
Read More
Indoco Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-10-27 08:03:35Indoco Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade to Sell from Strong Sell, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This article analyses these technical parameters in detail, providing investors with a comprehensive view of the stock’s current market positioning and outlook.
Read MoreDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
18-Nov-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Suresh G Kare & Aruna Kare
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
13-Nov-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi M Panandikar & Others
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
09-Nov-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Suresh G Kare
Corporate Actions
No Upcoming Board Meetings
Indoco Remedies Ltd has declared 10% dividend, ex-date: 10 Sep 26
Indoco Remedies Ltd has announced 2:10 stock split, ex-date: 17 May 12
Indoco Remedies Ltd has announced 1:2 bonus issue, ex-date: 17 May 12
No Rights history available